| CARDIAC
SAFETY / QTc STUDIES
We
have an ICU-like unit for the conduct of Thorough QT/QTc studies
under the guidance of the E14 document promulgated by ICH and the
FDA Guidance for Industry. Containing up to 48 beds in a single
large room the unit is specifically designed to allow control of
all environmental factors that might adversely influence a thorough
QT/QTc study. All forty eight subjects are exposed to the same temperature,
humidity, noise levels and other conditions. Thus, controlling to
a much greater extent than usual the factors that may cause variation
in the data collected in these difficult to control cardiovascular
studies. Even though most data in the unit is collected with either
12 lead holter recordings (such as Mortara H-12+) or other 12 lead
collection machines, it was opted to flexibly include bedside monitoring
including pulse oximetry, ECG, vital signs and ready access to emergency
equipment if it is needed. In this way the unit actually is a fully
equipped cardiovascular research unit that can be focused on repolarization
studies.
Guidance for Industry:
E14 Clinical Evaluation of QT/QTc Interval Prolongation and
Proarrhythmic Potential for Non-Antiarrhythmic Drugs
2005 US Food and Drug Administration
|
DOWNLOAD |
|
|